← Back to Search

Behavioural Intervention

Strength Training Intensity for Osteoporosis

N/A
Recruiting
Led By Lora Giangregorio, PhD
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Self-reported as postmenopausal for ≥ 2 years, OR postmenopausal stats confirmed via blood test (female participants only)
Age 50 or over
Must not have
Has conditions affecting bone health
Is unable to communicate in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will look at different types of exercise to see what is most effective for people with osteoporosis in order to prevent fractures, disability, and premature death.

Who is the study for?
This trial is for individuals over 50 with low bone density or high fracture risk who have declined osteoporosis medication. Participants must be postmenopausal, willing to exercise twice weekly, and fully vaccinated against COVID-19. Those already doing similar training or with conditions affecting bone health cannot join.
What is being tested?
The study tests the effects of different exercise intensities on bone strength in people at risk for fractures due to low bone mineral density. It compares supervised strength training at two intensity levels versus home exercises.
What are the potential side effects?
While specific side effects are not listed, resistance training can sometimes lead to muscle soreness, joint pain, or injury if not done correctly. The trial aims to find safe exercise intensities for those with fragile bones.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman who has been postmenopausal for 2 years or more, or this has been confirmed by a blood test.
Select...
I am 50 years old or older.
Select...
I have received 2 COVID-19 vaccinations.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a condition that affects my bone health.
Select...
I cannot communicate in English.
Select...
I have major surgery planned within a year.
Select...
I have had cancer other than non-melanoma skin cancer in the last 2 years.
Select...
I am receiving care focused on relieving symptoms.
Select...
I have had a spine fracture in the past year or a limb fracture in the past 6 months.
Select...
I had a joint replacement within the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Lumbar Spine bone mineral density (BMD)
Secondary study objectives
10 Metre Walk Test.
30 Second Chair Stand Test.
6 Minute Walk Test.
+27 more
Other study objectives
Dietary Intake

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Supervised strength training (group 2)Experimental Treatment1 Intervention
In-person, supervised muscle strengthening exercises twice weekly at a specific intensity.
Group II: Supervised strength training (group 1)Experimental Treatment1 Intervention
In-person, supervised muscle strengthening exercises twice weekly at a specific intensity.
Group III: Home exerciseActive Control1 Intervention
Home exercise program, with biweekly group virtual education and exercise classes.

Find a Location

Who is running the clinical trial?

University of WaterlooLead Sponsor
127 Previous Clinical Trials
214,508 Total Patients Enrolled
University of SaskatchewanOTHER
256 Previous Clinical Trials
154,128 Total Patients Enrolled
University Health Network, TorontoOTHER
1,523 Previous Clinical Trials
503,014 Total Patients Enrolled

Media Library

Supervised strength training (group 1) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05541432 — N/A
Osteopenia Research Study Groups: Supervised strength training (group 2), Home exercise, Supervised strength training (group 1)
Osteopenia Clinical Trial 2023: Supervised strength training (group 1) Highlights & Side Effects. Trial Name: NCT05541432 — N/A
Supervised strength training (group 1) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05541432 — N/A
Osteopenia Patient Testimony for trial: Trial Name: NCT05541432 — N/A
~145 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top